Insulet Corporation
Symbol: PODD (NASDAQ)
329.33
▲ (0.11%) 0.360
Company Description:
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.
Key Stats
- Today's Open: $332.98
- Today's High: $335.905
- Today's Low: $321.665
- Today's Volume: 557.33K
- Yesterday Close: $328.97
- Yesterday High: $329.97
- Yesterday Low: $322.83
- Yesterday Volume: 441.45K
- Last Min Volume: 4
- Last Min High: $329.33
- Last Min Low: $329.33
- Last Min VWAP: $329.33
Company Profile
- Name: Insulet Corporation
- Website: https://www.insulet.com
- Listed Date: 2007-05-15
- Location: ACTON, MA
- Market Status: Active
- CIK Number: 0001145197
- SIC Code: 3841
- SIC description: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
- Market Cap: $23.16B
- Round Lot: 100
- Outstanding Shares: 70.39M
- Asset Type: CS
RECENT FILINGS FOR PODD
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-10-02 | 4 | View |
| 2025-09-16 | 144 | View |
| 2025-09-16 | 8-K | View |
| 2025-09-09 | 4 | View |
| 2025-09-09 | 4 | View |
| 2025-09-08 | 144 | View |
| 2025-09-08 | 144 | View |
| 2025-08-22 | 4 | View |
| 2025-08-21 | 4 | View |
| 2025-08-21 | 144 | View |
| 2025-08-13 | SCHEDULE 13G/A | View |
| 2025-08-08 | 4 | View |
| 2025-08-07 | 10-Q | View |
| 2025-08-07 | 144 | View |
| 2025-08-07 | 8-K | View |
| 2025-08-05 | 4 | View |
| 2025-07-29 | 3 | View |
| 2025-06-16 | 4 | View |
| 2025-06-16 | 4 | View |
| 2025-06-13 | 144 | View |
Latest News on PODD